Abstract:
An organometallic compound represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 0, 1, or 2, n2 is 1, 2, or 3, provided that the sum of n1 and n2 is at least 3, wherein CY1, CY2, CY3, R10, R20, R30, X1, X2, Y1 to Y8, and b10 to b30 are as described herein, and wherein * and *′ each indicate a binding site to M1.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as defined in the specification.
Abstract:
An organometallic compound represented by one of Formulae 1 to 4: wherein, in Formulae 1 to 4, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein in Formula 1, L1 is a divalent ligand represented by Formula 2, L2 is selected from a monovalent organic ligand, a divalent organic ligand, and trivalent organic ligand, and L2 is not a ligand represented by Formula 2; wherein in Formulae 1 and 2, M, CY1, CY2, Y1, Y2, Z1, a1, n1, and n2 are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1 or Formula 2: wherein in Formula 1 and Formula 2, CY1 to CY8, L1, M1, M2, Y1 to Y10, Z1 to Z8, n1, and a1 to a8 are described in the specification.
Abstract:
An organometallic compound represented by Formula 1:
M1(L1)n1(L2)n2 Formula 1
wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, and L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2,
wherein X1 and X2 are each independently C or N, Y1 is O, S, Se, C(R5)(R6), or N(R7), X44 is N or C(R44), X45 is N or C(R45), X46 is N or C(R46), and X47 is N or C(R47), and the other substituent groups are as defined herein.
Abstract:
An organometallic compound represented by Formula 1:
M1(Ln1)n1(Ln2)n2 Formula 1
wherein, in Formula 1, M1 is a transition metal; Ln1 is a ligand represented by Formula 1A; Ln2 is a ligand represented by Formula 1B; n1 is 1 or 2, and n2 is 1 or 2:
wherein ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; ring CY41 is a group represented by Formula 41; X1 is C or N, and X2 is C or N; Y41 is O, S, Se, C(R3)(R4), N(R3), or B(R3); Y42 is O, S, Se, C(R5)(R6), N(R5), or B(R5); and the other substituents are as described in the detailed description.
Abstract:
An organometallic compound represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein M1 is a transition metal, Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 1 or 2, and n2 is 1 or 2: wherein ring CY1, ring CY2, ring CY3, X1, X2, X41, X42, R1 to R6, R10, R20, R30, R40, b10, b20, b30, and b40 are as described in the detailed description, and * and *′ each indicate a binding site to M1.
Abstract:
An organometallic compound represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein, Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 1 or 2, and n2 is 1 or 2, wherein ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, ring CY41 is a benzene group, ring CY42 is a 5-membered aromatic heterocyclic group, X1 is C or N, X2 is C or N, Y1 is O, S, Se, C(R3)(R4), N(R3), or B(R3), and R1 to R4, R10, R20, R31 to R34, R40, b10, b20, and b40 are as described herein.